DETECT EARLY,
SAVE LIVES
GLOBALLY
Introducing MiraScope® - a handheld, non-invasive breast cancer screening device designed to bring early detection to underserved communities worldwide.
The Problem
Breast cancer is the most common cancer globally and a leading cause of deaths amongst women
of cases in LMICs are diagnosed too late due to lack of access to screening
of women in LMICs get screened for breast cancer
survival rate when breast cancer is caught early
Introducing,
MiraScope®
A handheld breast cancer screening device that detects abnormal tissue stiffness, allowing for early triage or referrals.
MiraScope®
Handheld Screening Device
How It Works
Simple, effective technology that detects tissue stiffness variations
Healthcare worker uses the handles to press MiraScope® against the patient's breast
Cancer tissue is 13x stiffer than surrounding tissue. Elastomeric lens deforms with the presence of a growth and creates a topographic highlight of the denser tissue
Measuring growth rings to track growths, which should be immediately further examined
Note: Clinical management decisions should only be made on the basis of the clinical and diagnostic examination (e.g. ultrasound or mammography)
Current Status
From field testing to IP protection, laying the groundwork for scalable impact
Piloted in outskirts of Kumasi, Ghana with OKB Hope Foundation
Filed provisional patent with U.S. Patent and Trademark Office
C-Corp in DE, USA with state of doing business in CT
Developing FDA regulatory strategy and preparing clinical trials
Impact in Action
Real-world testing and community outreach in Ghana, demonstrating MiraScope®'s effectiveness in underserved communities
Community Training
Training local healthcare workers on proper MiraScope® examination techniques
Patient Care
Providing accessible breast cancer screening to women in rural communities
Field Testing
Real-world validation and piloting of MiraScope® effectiveness in resource-limited settings
Join Us in the Fight Against Breast Cancer
Partner with us to bring life-saving screening technology to communities that need it most.